Ciaglia, E., Grimaldi, M., Abate, M., Scrima, M., Rodriquez, M., Laezza, C., . . . Bifulco, M. (2017). The isoprenoid derivative N(6)‐benzyladenosine CM223 exerts antitumor effects in glioma patient‐derived primary cells through the mevalonate pathway. Br J Pharmacol.
Dyfyniad Arddull ChicagoCiaglia, Elena, et al. "The Isoprenoid Derivative N(6)‐benzyladenosine CM223 Exerts Antitumor Effects in Glioma Patient‐derived Primary Cells Through the Mevalonate Pathway." Br J Pharmacol 2017.
Dyfyniad MLACiaglia, Elena, et al. "The Isoprenoid Derivative N(6)‐benzyladenosine CM223 Exerts Antitumor Effects in Glioma Patient‐derived Primary Cells Through the Mevalonate Pathway." Br J Pharmacol 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.